784
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Risk factors of ventilator-associated pneumonia in elderly patients receiving mechanical ventilation

, , , , , & show all
Pages 1027-1038 | Published online: 07 Jun 2019

References

  • American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. doi:10.1164/rccm.200405-644ST15699079
  • Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208. doi:10.1186/cc1371225029020
  • Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA. 1995;274(8):639–644.7637145
  • Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867–903. doi:10.1164/ajrccm.165.8.210610411934711
  • Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care–associated pneumonia, 2003: recommendations of CDC and the healthcare infection control practices advisory committee. MMWR Recomm Rep. 2004;53(RR–3):1–36.
  • Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115–2121. doi:10.1378/chest.122.6.211512475855
  • Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31(5):1312–1317. doi:10.1097/01.CCM.0000063087.93157.0612771596
  • Baid H. Patient safety: identifying and managing complications of mechanical ventilation. Crit Care Nurs Clin North Am. 2016;28(4):451–462. doi:10.1016/j.cnc.2016.07.00528236392
  • Jovanovic B, Milan Z, Markovic-Denic L, et al. Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre. Int J Infect Dis. 2015;38:46–51. doi:10.1016/j.ijid.2015.07.00526166697
  • Blot S, Koulenti D, Dimopoulos G, et al. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients. Crit Care Med. 2014;42(3):601–609. doi:10.1097/01.ccm.0000435665.07446.5024158167
  • File TM Jr. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines. Clin Infect Dis. 2010;51(Suppl 1):S42–7. doi:10.1086/65304820597671
  • Rodrigues DO, Cezário RC, Filho PP. Ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa vs. other microorganisms at an adult clinical-surgical intensive care unit in a Brazilian University Hospital: risk factors and outcomes. Int J Med Sci. 2009;1:432–437.
  • Morehead RS, Pinto SJ. Ventilator-associated pneumonia. Arch Intern Med. 2000;160(13):1926–1936. doi:10.1001/archinte.160.13.192610888967
  • Khattab AA, El-Lahony DM, Fathy W. Ventilator associated pneumonia in a neonatal intensive care unit. J Am Sci. 2013;9(11):251–258.
  • Makris D, Luna C, Nseir S. Ten ineffective interventions to prevent ventilator- associated pneumonia. Intensive Care Med. 2018;44(1):83–86. doi:10.1007/s00134-017-4978-728470348
  • Corrado RE, Lee D, Lucero DE, et al. Burden of adult community-acquired, healthcare-associated, hospital-acquired, and ventilator-associated pneumonia-New York City, 2010-2014. Chest. 2017;S0012369217307791. doi:10.1016/j.chest.2017.04.162
  • Apisarnthanarak A, Pinitchai U, Thongphubeth K, et al. Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis. 2007;45(6):704–711. doi:10.1086/52098717712753
  • Kulvatunyou N, Boonbarwornrattanakul A, Soonthornkit Y, Kocharsanee C, Lertsithichai P. Incidence of ventilator-associated pneumonia (VAP) after the institution of an educational program on VAP prevention. J Med Assoc Thai. 2007;90(1):89–95.17621738
  • Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest. 2001;120(2):555–561. doi:10.1378/chest.120.2.55511502658
  • Wang F, Wu Y, Bo L, et al. The timing of tracheotomy in critically ill patients undergoing mechanical ventilation: a systematic review and meta-analysis of randomized controlled trials. Chest. 2011;140(6):1456–1465. doi:10.1378/chest.11-040121940770
  • Griffiths J, Barber VS, Morgan L, et al. systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ. 2005;330(5):1243–1246. doi:10.1136/bmj.38467.485671.E015901643
  • Sands KM, Wilson MJ, Lewis MA, et al. Respiratory pathogen colonization of dental plaque, the lower airways, and endotracheal tube biofilms during mechanical ventilation. J Crit Care. 2017;37:30–37. doi:10.1016/j.jcrc.2016.07.019
  • Machado MC, Webster TJ. Decreased Pseudomonas aeruginosa biofilm formation on nanomodified endotracheal tubes: a dynamic lung mode. Int J Nanomedicine. 2016;11:3825–3831. doi:10.2147/IJN.S108253
  • Nakaviroj S, Cherdrungsi R, Chaiwat O. Incidence and risk factors for ventilator-associated pneumonia in the surgical intensive care unit, Siriraj Hospital. J Med Assoc Thai. 2014;97(Suppl 1):S61–8.24855844
  • Kollef MH, Von Harz B, Prentice D, et al. Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest. 1997;112(3):765–773. doi:10.1378/chest.112.3.7659315813
  • Torres A, Gatell JM, Aznar E, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med. 1995;152(1):137–141. doi:10.1164/ajrccm.152.1.75998367599812
  • Widmer AF. Infection control and presentation strategies in the ICU. Intensive Care Med. 1994;20(Suppl.4):7–11. doi:10.1007/BF1713976
  • Rea-Neto A, Youssef NC, Tuche F, et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care. 2008;12(2):R56. doi:10.1186/cc699618426596
  • Charles MP, Easow JM, Joseph NM, et al. Incidence and risk factors of ventilator associated pneumonia in a tertiary care hospital. Australas Med J. 2013;6(4):178–182. doi:10.4066/AMJ.2013.162723671462
  • Lipovy B, Rihova H, Gregorova N, et al. Epidemiology of ventilator-associated tracheobronchitis and ventilator-associated pneumonia in patients with inhalation injury at the burn centre in Brno (Czech Republic). Ann Burns Fire Disasters. 2011;24(3):120–125.22396669
  • Boots RJ, Lipman J, Bellomo R, et al. Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesth Intensive Care. 2005;33(1):101–111. doi:10.1177/0310057X050330011615957699
  • System N. National Nosocomial infections surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. A report from the NNIS system. Am J Infect Control. 1999;27(6):520–532. doi:10.1016/S0196-6553(99)70031-310586157
  • Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142(3):523–528. doi:10.1164/ajrccm/142.3.5872202245
  • Sofianou DC, Constandinidis TC, Yannacou M, Anastasiou H, Sofianos E. Analysis of risk factors for ventilator-associated pneumonia in a multidisciplinary intensive care unit. Eur J Clin Microbiol Infect Dis. 2000;19(6):460–463. doi:10.1007/s10096000023610947222
  • Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO17507545
  • Restrepo MI, Sibila O, Anzueto A. Pneumonia in patients with chronic obstructive pulmonary disease. Tuberc Respir Dis. 2018;81(3):187–197. doi:10.4046/trd.2018.0030
  • Sundar KM, Nielsen D, Sperry P. Comparison of ventilator-associated pneumonia (VAP) rates between different ICUs: implications of a zero VAP rate. J Crit Care. 2012;27(1):26–32. doi:10.1016/j.jcrc.2011.05.01921737241
  • Hadda V, Dubey G, Nallan R, et al. Impact of ventilator associated pneumonia on outcome in patients with chronic obstructive pulmonary disease exacerbation. Lung India. 2014;31(1):4–8. doi:10.4103/0970-2113.12588624669074
  • Koulenti D, Blot S, Dulhunty JM, et al. COPD patients with ventilator-associated pneumonia: implications for management. Eur J Clin Microbiol Infect Dis. 2015;34(12):2403–2411. doi:10.1007/s10096-015-2424-826407622
  • Charles MP, Kali A, Easow JM, et al. Ventilator-associated pneumonia. Australas Med J. 2014;7(8):334–344. doi:10.4066/AMJ.2014.210525279009
  • Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1545–1549.7952612
  • Talon D, Mulin B, Rouget C, et al. Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa. Am J Respir Crit Care Med. 1998;157(3 Pt 1):978–984.9517620
  • Charles EL, Nicolas B, Alain C, et al. Delivering antibiotics to the lungs of patients with ventilation-associated pneumonia: an update. Expert Rev Anti Infect Ther. 2013;11(5):511–521. doi:10.1586/eri.13.3623627857
  • Kadri SS, O’Grady NP. Review: short and long courses of antibiotics do not differ for mortality in ventilator-associated pneumonia. Ann Intern Med. 2014;160(10):JC3–JC3.
  • Almuneef M, Memish ZA, Balkhy HH, Alalem H, Abutaleb A. Ventilator-associated pneumonia in a pediatric intensive care unit in Saudi Arabia: a 30-month prospective surveillance. Infect Control Hosp Epidemiol. 2004;25(9):753–758. doi:10.1086/50247215484800
  • Bauer TT, Ferrer R, Angrill J, Schultze-Werninghaus G, Torres A. Ventilator-associated pneumonia: incidence, risk factors, and microbiology. Semin Respir Infect. 2000;15(4):272–279. doi:10.1053/srin.2000.2093811220409
  • Bonten MJ, Weinstein RA. Infection control in intensive care units and prevention of ventilator-associated pneumonia. Semin Respir Infect. 2000;15(4):327–335. doi:10.1053/srin.2000.2093611220415
  • Kaufmann I, Briegel J, Schliephake F, et al. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Med. 2008;34(2):344–349. doi:10.1007/s00134-007-0865-y17906853
  • Steinberg KP, Hudson LD, Goodman RB, et al. National heart, lung, and blood institute acute respiratory distress syndrome (ARDS) clinical trials network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671–1684. doi:10.1056/NEJMoa05169316625008
  • Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671–1684. doi:10.1056/NEJMoa05169316625008
  • Roquilly A, Mahe PJ, Seguin P, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA. 2011;305(12):1201–1209. doi:10.1001/jama.2011.36021427372
  • Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest. 2005;128(3):1650–1656. doi:10.1378/chest.128.3.165016162771
  • Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321–1328. doi:10.1016/S0140-6736(04)17188-215474134
  • Chaari A, Habib ME, Ghdhoun H, et al. Does low-dose hydrocortisone therapy prevent ventilator-associated pneumonia in trauma patients? Am J Ther. 2013;22(1):22–28. doi:10.1097/MJT.0b013e3182691af0
  • Kaye KS, Marchaim D, Smialowicz C, Bentley L. Suction regulators: a potential vector for hospital-acquired pathogens. Infect Control Hosp Epidemiol. 2010;31(7):772–774. doi:10.1086/65382020486854